Mayumi Ono

14.8k total citations · 1 hit paper
214 papers, 12.1k citations indexed

About

Mayumi Ono is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mayumi Ono has authored 214 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 67 papers in Oncology and 41 papers in Cancer Research. Recurrent topics in Mayumi Ono's work include Angiogenesis and VEGF in Cancer (51 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (17 papers). Mayumi Ono is often cited by papers focused on Angiogenesis and VEGF in Cancer (51 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (17 papers). Mayumi Ono collaborates with scholars based in Japan, United States and Spain. Mayumi Ono's co-authors include Michihiko Kuwano, Kimitoshi Kohno, Hiroto Izumi, Shigeo Yoshida, Kosuke Watari, M Kuwano, Tadahisa Shono, Akihiko Kawahara, Tatsuro Ishibashi and Yuji Basaki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Mayumi Ono

212 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Involvement of Interleukin-8, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Tumor Necrosis Factor Alpha-Dependent Angiogenesis

1997 573 citations Mayumi Ono, Hiroto Izumi et al. profile →

Peers

Countries citing papers authored by Mayumi Ono

Since Specialization

Citations

This map shows the geographic impact of Mayumi Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Ono more than expected).

Fields of papers citing papers by Mayumi Ono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Ono. The network helps show where Mayumi Ono may publish in the future.

Co-authorship network of co-authors of Mayumi Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Mayumi Ono. A scholar is included among the top collaborators of Mayumi Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayumi Ono. Mayumi Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin 2022 ·The Kurume Medical Journal ·(unknown), Naotake Tsuda, (unknown), (unknown), (unknown), (unknown), (unknown), Shin Nishio, Tomohiko Yamaguchi, Sakiko Sanada, Jun Akiba, Michihiko Kuwano, Mayumi Ono, Kimio Ushijima	1
2	Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma 2021 ·FEBS Open Bio ·(unknown), Akira Imaizumi, Noritaka Komune, Mayumi Ono, Kuniaki Sato, (unknown), Akiko Fujimura, (unknown), Takahiro Hongo, Ryutaro Uchi, Hideya Onishi, Takashi Nakagawa	4
3	Targeting Phosphorylation of Y-Box–Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance 2019 ·Molecular Cancer Therapeutics ·Tomohiro Shibata, Kosuke Watari, Akihiko Kawahara, Tomoya Sudo, Satoshi Hattori, Yûichi Murakami, Hiroto Izumi, Junji Itou, Masakazu Toi, Jun Akiba, Yoshito Akagi, Maki Tanaka, Michihiko Kuwano, Mayumi Ono	47
4	Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma 2019 ·Cancer Research ·Hiroshi Ito, Kosuke Watari, Tomohiro Shibata, Tomofumi Miyamoto, Yûichi Murakami, Yukiko Nakahara, Hiroto Izumi, Hiroaki Wakimoto, Michihiko Kuwano, Tatsuya Abé, Mayumi Ono	26
5	The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial 2014 ·Clinical Cancer Research ·Carlota Costa, Miguel Angel Molina, Ana Drozdowskyj, Ana Giménez‐Capitán, Jordi Bertrán-Alamillo, Niki Karachaliou, Radj Gervais, Bartomeu Massutí, Jia Wei, Teresa Morán, Margarita Majem, Enriqueta Felip, Enric Carcereny, Rosario García‐Campelo, Santiago Viteri, Miquel Tarón, Mayumi Ono, Petros Giannikopoulos, Trever G. Bivona, Rafael Rosell	180
6	Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling 2013 ·Cancer Research ·(unknown), Akihiko Kawahara, Kosuke Watari, Yûichi Murakami, Kahori Sonoda, (unknown), Hideaki Fujita, Masayoshi Kage, Hidetaka Uramoto, Carlota Costa, Michihiko Kuwano, Mayumi Ono	129
7	Circadian Regulation of mTOR by the Ubiquitin Pathway in Renal Cell Carcinoma 2013 ·Cancer Research ·Hiroyuki Okazaki, Naoya Matsunaga, Takashi Fujioka, (unknown), (unknown), (unknown), Mayumi Ono, Michihiko Kuwano, Satoru Koyanagi, Shigehiro Ohdo	50
8	Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin 2011 ·Molecular Cancer Therapeutics ·Kunio Okamoto, Isamu Okamoto, Erina Hatashita, Kiyoko Kuwata, Haruka Yamaguchi, Aya Kita, Kentaro Yamanaka, Mayumi Ono, Kazuhiko Nakagawa	59
9	Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor–Activating Mutations 2010 ·Cancer Research ·Chizuko Yamamoto, Yuji Basaki, Akihiko Kawahara, Kazutaka Nakashima, Masayoshi Kage, Hiroto Izumi, Kimitoshi Kohno, Hidetaka Uramoto, Kosei Yasumoto, Michihiko Kuwano, Mayumi Ono	141
10	Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma 2009 ·Clinical Cancer Research ·Daisuke Aoki, Yoshinao Oda, Satoshi Hattori, Kenichi Taguchi, Yoshihiro Ohishi, Yuji Basaki, Shinji Oie, Nao Suzuki, Suminori Kono, Masazumi Tsuneyoshi, Mayumi Ono, Takashi Yanagawa, Michihiko Kuwano	55
11	N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of κB Kinase β Expression 2009 ·Cancer Research ·Fumihito Hosoi, Hiroto Izumi, Akihiko Kawahara, Yûichi Murakami, Hisafumi Kinoshita, Masayoshi Kage, Kazuto Nishio, Kimitoshi Kohno, Michihiko Kuwano, Mayumi Ono	88
12	Overexpression of Cap43 is associated with malignant status of esophageal cancer. 2009 ·PubMed ·Makoto Sohda, Yasushi Mochida, Hiroyuki Kato, Tatsuya Miyazaki, Masanobu Nakajima, Minoru Fukuchi, Ryokuhei Manda, Yasuyuki Fukai, Norihiro Masuda, Mayumi Ono, Michihiko Kuwano, Hiroyuki Kuwano	11
13	Molecular Basis for the Induction of an Angiogenesis Inhibitor, Thrombospondin-1, by 5-Fluorouracil 2008 ·Cancer Research ·Hong‐Ye Zhao, Akio Ooyama, Masatatsu Yamamoto, Ryuji Ikeda, Misako Haraguchi, Sho Tabata, Tatsuhiko Furukawa, Xiaofang Che, Shaoxuan Zhang, Toshinori Oka, Masakazu Fukushima, Masayuki Nakagawa, Mayumi Ono, Michihiko Kuwano, Shin‐ichi Akiyama	33
14	Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis 2007 ·Cancer Science ·Yusuke Kimura, Kosuke Watari, Abbas Fotovati, Fumihito Hosoi, Kosei Yasumoto, Hiroto Izumi, Kimitoshi Kohno, Kazuo Umezawa, Haruo Iguchi, Kazuo Shirouzu, (unknown), Michihiko Kuwano, Mayumi Ono	108
15	The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-α 2006 ·International Journal of Oncology ·Shinji Oie, Mayumi Ono, Hirohisa Yano, Yuichiro Maruyama, (unknown), Yuji Yamada, Takato Ueno, Masamichi Kojiro, Kazuyuki Hirano, Michihiko Kuwano	14
16	Infiltration of COX-2–expressing macrophages is a prerequisite for IL-1β–induced neovascularization and tumor growth 2005 ·Journal of Clinical Investigation ·Shintaro Nakao, Takashi Kuwano, Chikako Tsutsumi‐Miyahara, (unknown), Yusuke Kimura, Shinjiro Hamano, Koh‐Hei Sonoda, Yasuo Saijo, Toshihiro Nukiwa, Robert M. Strieter, Tatsuro Ishibashi, Michihiko Kuwano, Mayumi Ono	246
17	Cyclooxygenase 2 is a key enzyme for inflammatory cytokine induced angiogenesis 2004 ·Investigative Ophthalmology & Visual Science ·Shintaro Nakao, Takashi Kuwano, Tatsuro Ishibashi, M Kuwano, Mayumi Ono	8
18	High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas. 2001 ·PubMed ·Akihiro Nishie, Katsuaki Masuda, (unknown), Toshiro Migita, Masazumi Tsuneyoshi, Kimitoshi Kohno, Taro Shuin, Seiji Naito, Mayumi Ono, Michihiko Kuwano	52
19	Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL-1α 2000 ·International Journal of Cancer ·Hitoe Torisu, Mayumi Ono, Hiromaro Kiryu, Masutaka Furue, Yasukazu Ohmoto, Juichiro NAKAYAMA, Yasuhiko Nishioka, Saburo Sone, Michihiko Kuwano	225
20	Regulation of angiogenesis by growth factors 1994 ·M Kuwano, Shin Ushiro, (unknown), Ken Samoto, Hiroto Izumi, (unknown), Tatsuya Abé, Takashi Nakamura, Mayumi Ono, Kimitoshi Kohno	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact